Exhibits and Industry Support

During The Liver Meeting Digital Experience™ (TLMdX), hepatologists and hepatology health professionals from across the nation and around the world will experience The Liver Meeting® in a new and exciting way on November 13-16, 2020. Liver disease research, treatment outcome discussions, and interaction among colleagues will all take place during this must-attend event. AASLD continues to be the leading organization focused solely on advancing the science and practice of hepatology and defines the cutting edge in the study and treatment of liver and biliary diseases and offers a premiere environment to discuss groundbreaking research and progressive clinical treatments.

TLMdX™ will be held on Freeman’s state-of-the-art virtual event platform. Exhibitors and Corporate Supporters will have countless options to customize their booths, and banner advertisements with their marketing materials, along with additional support events and opportunities. Each option allows your organization to directly connect and interact with conference attendees.

Unlike in-person events, TLMdX can track participant engagement through online tools. You can assess return on investment by tracking the reach of your content, identifying who engaged, and accessing emails to follow up after the conference.

Download our Prospectus and Application and Contract.

Satellite Symposia

AASLD offers commercial supporters of The Liver Meeting Digital Experience the opportunity to organize a limited number of independent educational symposia to be presented during TLMdX for registered participants. These symposia will take place at designated times following scheduled educational events of TLMdX and are designed to meet the continuing medical education needs of the hepatology community.

Unraveling the Intricacies of HCC Management With Your Multidisciplinary Team: A Closer Look at Effective Selection and Sequencing Strategies in an Expanding Treatment Landscape
Applying Advances in HRS Management
Stronger Together: An Emerging Era of Combination Regimens for Unresectable HCC
Potential Therapeutic Roles for IBAT Inhibitors in Cholestatic and Metabolic Liver Diseases

Product Theaters

Product Theaters are 30-minute marketing presentations about your company’s products or services. These sessions do not offer CME credit; rather, they give exhibitors the freedom to create a presentation centered on their company’s products and/or services.

Management of Overt Hepatic Encephalopathy in an Expanding Population of Patients with Cirrhosis; Considerations for a COVID-19 Environment
Resmetirom for the Treatment of NASH: Early Data from the Phase 3 MAESTRO Clinical Trials
LENVIMA® Monotherapy as First-Line Treatment Option for Patients with Unresectable Hepatocellular Carcinoma
Clinical Management of HCC With CABOMETYX®
Biomarkers in Liver Transplantation: The Next Frontier
Session 1: Seeking a Cure for Chronic Hepatitis B: The Need, The Mechanisms and The Treatment Goals
Session 2: Seeking a Cure for Chronic Hepatitis B: The Need, The Mechanisms and The Treatment Goals – Audience Q&A
Advancement in the 1L Treatment of Unresectable and Metastatic HCC A Review of the IMbrave150 Trial